Lobular carcinoma in situ of the breast

Lobular carcinoma in situ (LCIS) of the breast is commonly identified as an incidental finding in breast biopsies performed because of either a mammographic abnormality or a palpable mass. Although long recognized as an entity, the significance and optimal treatment of LCIS remains controversial. In...

Full description

Saved in:
Bibliographic Details
Published inSeminars in surgical oncology Vol. 12; no. 5; p. 314
Main Authors Goldschmidt, R A, Victor, T A
Format Journal Article
LanguageEnglish
Published United States 01.09.1996
Subjects
Biopsy
Breast Neoplasms - diagnosis
Breast Neoplasms - surgery
Carcinoma in Situ - diagnosis
Carcinoma in Situ - surgery
Carcinoma, Lobular - diagnosis
Carcinoma, Lobular - surgery
Female
Humans
Mammography
Mastectomy
Risk Factors
Online AccessGet more information

Cover

More Information
Summary:Lobular carcinoma in situ (LCIS) of the breast is commonly identified as an incidental finding in breast biopsies performed because of either a mammographic abnormality or a palpable mass. Although long recognized as an entity, the significance and optimal treatment of LCIS remains controversial. Initially regarded as a pre-invasive form of breast cancer analogous to ductal carcinoma in situ (DCIS), LCIS was treated by mastectomy. As evidence mounted for an equal risk of invasive carcinoma in both breasts, bilateral mastectomy was advocated by some. More recent studies suggest that LCIS is a marker for increased risk rather than a true precursor of invasive carcinoma, and this allows a more conservative approach. The pathologic aspects and natural history of LCIS are discussed.
ISSN:8756-0437
DOI:10.1002/(SICI)1098-2388(199609/10)12:5<314::AID-SSU5>3.0.CO;2-G